Načítá se...
Intranasal insulin and orexins to treat age-related cognitive decline
The intranasal (IN) administration of neuropeptides, such as insulin and orexins, has been suggested as a treatment strategy for age-related cognitive decline (ARCD). Because dysfunctional neuropeptide signaling is an observed characteristic of ARCD, it has been suggested that IN delivery of insulin...
Uloženo v:
| Vydáno v: | Physiol Behav |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053680/ https://ncbi.nlm.nih.gov/pubmed/33621561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.physbeh.2021.113370 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|